IDOVEN new member of the MAESTRIA H2020 consortium | IDOVEN

From IDOVEN we are very honoured and grateful to be able to announce our incorporation as members of the MAESTRIA H2020 Consortium.

H2020 is the largest EU Research and Innovation Programme in history with almost 80 billion euros of funding available over 7 years.

MAESTRIA is a collaborative project of Europe's leading centres in Atrial Fibrillation research funded by the European Commission (European Union Research and Innovation Programme H2020).

The MAESTRIA Consortium (Machine Learning and Artificial Intelligence for Early Detection of Stroke and Atrial Fibrillation) Consortium is creating the largest and most diverse database ever built on atrial fibrillation in the history of medicine.

This digital platform will be designed to support doctors and their patients in achieving greater diagnostic accuracy to increase the effectiveness and efficiency of treatments.The digital platform will be designed to support doctors and their patients to achieve greater diagnostic accuracy, as well as the prevention of complications of atrial cardiomyopathy, such as atrial fibrillation, thrombus, stroke or stroke.

The project team MAESTRIA together with IDOVEN and the 17 partners which are part of the consortium, aims to develop and validate the first integrative digital diagnostic platform for the diagnosis of atrial fibrillation. Atrial fibrillation is the most common sustained cardiac arrhythmia in the general population. The latest data indicate that in people over 40 years of age, this disease affects more than > 4% of the population. It is a public health problem of great magnitude, which is the reason for this alliance between major European research centres to help improve its prevention, diagnosis and treatment.

The goal is to create multi-parametric digital tools based on a new generation of biomarkers integrating artificial intelligence (AI) processing and big data from cutting-edge imaging, electrocardiography and omics technologies.

IDOVEN is one of the partners of this prestigious MAESTRIA Consortium which has obtained a grant of 14 million euros in funding from the European Horizon 2020 funds.

This project, which will undoubtedly shape the future of digital diagnosis of atrial fibrillation, is coordinated by the Sorbonne University in Paris (Principal Investigator: Stéphane Hatem), and involves 17 other European partners: University of Oxford (UK), University of Birmingham (UK), Kompetenznetz Vorhofflimmern ev (Germany), Essen University Hospital (Germany), Maastricht University (Netherlands), National and Kapodistrian University of Athens (Greece), Centro Nacional de Investigaciones Cardiovasculares CNIC (Spain), Centre de recherche du CHUS (Canada), Siemens Healthcare GMBH (Germany) Caristo diagnostics (UK), Owkin (France), Preventicus GMBH (Germany), Yourrhythmics (The Netherlands) and IDOVEN (Spain).

For IDOVEN it is a real pleasure to become part of the MAESTRIA consortium to continue with our goal to help and prevent early and non-invasive cardiac problems through technology and artificial intelligence.

Recent articles

Read All

Idoven raises $19.8 million in funding to redefine detection and precision medicine of cardiovascular diseases with AI

[VIDEO] Manuel Marina, CEO at Idoven, tell you more about our company and the Serie A round

IDOVEN receives €6.5 million of funding from the European Innovation Council